Author/Authors :
Abdessamad, Arabi University Hospital - Department of Haematology and bone marrow transplantation, Algeria , Brahimi, M . University Hospital - Department of Haematology and bone marrow transplantation, Algeria , Bekadja, M.A . University Hospital - Department of Haematology and bone marrow transplantation, Algeria , Saidi, D. Oran University - Hematology Service, Hospital Centre , Touhami, H . Oran University - Hematology Service, Hospital Centre
Abstract :
Lymphoma is a hematologic malignancy characterized by nodal or extranodal malignant infiltration by monoclonal lymphoid cells (B lineage cells in 70% of the cases). Its etiology is not precisely known. Prolonged life expectancy has resulted in increase of the disease incidence. Marginal zone lymphoma is a low-grade small B-cell lymphoma incorporated in the World Health Organization classification.1,2 Low-grade lymphomas usually demonstrate a characteristic natural history with multiple remissions and relapses.
Keywords :
Marginal zone lymphoma , Myeloproliferative disorders , Flow cytometry , Molecular biology , Bone marrow
